title: The effect of neurointermediate lobe denervation on hypothalamic neuroendocrine dopaminergic neurons.
abstract: The contribution of tuberohypophyseal and periventricular-hypophyseal dopaminergic neurons to the regulation of the secretion of prolactin (PRL) has yet to be clarified. In this study, we used pituitary stalk compression to disrupt hypothalamic neural input to the neurointermediate lobe (NIL). Neurointermediate lobe denervation (NIL-D) selectively disrupts the axons of tuberohypophyseal and periventricular-hypophyseal dopaminergic neurons, while leaving tuberoinfundibular dopaminergic neurons and the vascular supply of the pituitary gland intact. NIL-D was performed in ovariectomized (OVX) rats. The concentration of DA and 3,4-dihydroxyphenylacetic acid (DOPAC) in the median eminence (ME) and various regions of the pituitary gland of OVX and OVX+NIL-D rats were measured by HPLC-EC. The concentration of PRL, alpha-melanocyte stimulating hormone (alpha-MSH), and luteinizing hormone (LH) in serum were determined by radioimmunoassay. Successful NIL-D was confirmed by increased water intake. One week after NIL-D, serum PRL and alpha-MSH were elevated, but there was no change in the concentration of LH in serum. The concentration of DA was increased in the median eminence (ME), decreased in the outer zone of the anterior lobe (AL-OZ), as well as the intermediate (IL) and neural lobes (NL), and remained unchanged in the inner zone of the anterior lobe (AL-IZ). The concentration of DOPAC was increased in the ME and NL, decreased in the IL, and remained unchanged in both the AL-IZ and AL-OZ. These data confirm that pituitary stalk compression denervates the NIL. Moreover, decreases in the concentration of DA in the IL and AL-OZ, coupled with elevation of serum PRL and alpha-MSH indicate that DA from the NIL contributes to the increased inhibition of the secretion of PRL and alpha-MSH in OVX rats.
authors.affiliation: Department of Biological Science, 208 Biomedical Research Facility, Program in Neuroscience, The Florida State University, Tallahassee, FL 32306-4340, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: DeMaria
authors.forename: D
authors.initials: D
authors.lastname: Zelena
authors.forename: M
authors.initials: M
authors.lastname: Vecsernyés
authors.forename: G M
authors.initials: GM
authors.lastname: Nagy
authors.forename: M E
authors.initials: ME
authors.lastname: Freeman
mesh_terms: D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003714:Denervation; D004298:Dopamine / Q000378:metabolism*; D004326:Drinking / Q000502:physiology; D005260:Female; D007031:Hypothalamus / Q000166:cytology / Q000378:metabolism*; D008473:Median Eminence / Q000378:metabolism; D009424:Nervous System Physiological Phenomena; D009474:Neurons / Q000502:physiology*; D009490:Neurosecretory Systems / Q000166:cytology / Q000378:metabolism*; D010052:Ovariectomy; D010904:Pituitary Gland, Posterior / Q000294:innervation*; D010907:Pituitary Hormones / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D010907:Pituitary Hormones; D015102:3,4-Dihydroxyphenylacetic Acid; D004298:Dopamine